Value & Access
The landscape for patient access and value demonstration continues to evolve across Europe. Developments in health technology assessment (HTA), regulatory collaboration and pharmaceutical policy are reshaping how innovative therapies reach patients.
This track explores the opportunities and challenges these changes create. It also looks ahead to emerging topics such as sustainability, environmental impact and the role of new technologies in healthcare decision-making.
Who Is This Track Designed For?
This track is designed for clinical, regulatory, patient, value demonstration and market access experts interested in how technology innovation connects with regulatory, HTA and local decision-making. It will explore how collaboration and engagement can improve patient access.
We invite abstracts that include perspectives from multiple functions and stakeholders, with regulatory and access perspectives represented at a minimum. Gender balance is encouraged.